The Maryland state legislature passed the nation's first bill allowing a state attorney general to sue pharmaceutical makers for price gouging on essential generic and off-patent drugs, prompting outcry from the generic trade group, the Association for Accessible Medicines, which argues the bill's language is too ambiguous and creates a level of uncertainty for its members. However, Maryland Attorney General Brian Frosh, who spearheaded the effort, told Inside Health Policy that the standards laid out in the bill are...